# FDA Inspection 888209 - Jubilant Cadista Pharmaceuticals, Inc. - July 08, 2014

Source: https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/8cad3d65-9f15-47dc-ba0a-7f522a6a38ba
Source feed: FDA_Inspections

> FDA Inspection 888209 for Jubilant Cadista Pharmaceuticals, Inc. on July 08, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 888209
- Company Name: Jubilant Cadista Pharmaceuticals, Inc.
- Inspection Date: 2014-07-08
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1120136 - 2020-02-28](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/31e698ef-594e-48c2-bf35-befb072ab907)
- [FDA Inspection 1120136 - 2020-02-28](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/53d5483f-7bb8-477d-87e8-7e8ef9b5e346)
- [FDA Inspection 1064090 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/c3fc5652-476b-4a43-a960-83d1429b5e85)
- [FDA Inspection 940733 - 2015-08-07](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/61646c48-445a-4b8e-a7b7-6b8d0e753a5f)
- [FDA Inspection 842669 - 2013-08-01](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/d0128a82-40bb-4e7b-8ad9-d2c69f19d50a)

Company: https://www.keypedia.com/companies/jubilant-cadista-pharmaceuticals-inc/bf3fdb52-1211-4c3c-8e41-659d9e4e13f9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c